Why tumours eat tryptophan

George C. Prendergast ()
Additional contact information
George C. Prendergast: George C. Prendergast is in the Lankenau Institute for Medical Research, Wynnewood, Pennsylvania 19096, USA.

Nature, 2011, vol. 478, issue 7368, 192-194

Abstract: Tumours increase their consumption of the amino acid tryptophan to evade immune control. But how does this work? A study shows that the main product of this consumption binds to a receptor involved in the immune system. See Article p.197

Date: 2011
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/478192a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:478:y:2011:i:7368:d:10.1038_478192a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/478192a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().